|
Mar 1
|
Kiniksa Pharmaceuticals Full Year 2023 Earnings: Beats Expectations
|
|
Mar 1
|
Chief Medical Officer John Paolini Sells 10,156 Shares of Kiniksa Pharmaceuticals Ltd (KNSA)
|
|
Feb 29
|
Are You Looking for a Top Momentum Pick? Why Kiniksa Pharmaceuticals, Ltd. (KNSA) is a Great Choice
|
|
Feb 29
|
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q4 2023 Earnings Call Transcript
|
|
Feb 28
|
Kiniksa Pharmaceuticals, Ltd. (KNSA) is on the Move, Here's Why the Trend Could be Sustainable
|
|
Feb 28
|
Kiniksa Pharmaceuticals, Ltd. (KNSA) Q4 Earnings and Revenues Surpass Estimates
|
|
Feb 28
|
Kiniksa Pharmaceuticals Ltd (KNSA) Reports Strong Revenue Growth in Q4 and Full-Year 2023
|
|
Feb 28
|
Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution
|
|
Jan 15
|
Investors in Kiniksa Pharmaceuticals (NASDAQ:KNSA) have seen returns of 30% over the past year
|
|
Jan 9
|
Is Kiniksa Pharmaceuticals (KNSA) Stock a Solid Choice Right Now?
|
|
Jan 4
|
Kiniksa Pharmaceuticals Provides Corporate Update
|
|
Dec 23
|
Chief Accounting Officer Michael Megna Sells 9,316 Shares of Kiniksa Pharmaceuticals Ltd (KNSA)
|
|
Nov 10
|
7 Underappreciated Biotech Stocks to Pick Up on the Cheap
|
|
Nov 4
|
Here's Why We're Not At All Concerned With Kiniksa Pharmaceuticals' (NASDAQ:KNSA) Cash Burn Situation
|
|
Aug 11
|
Fairmount Funds Management LLC Acquires New Stake in Kiniksa Pharmaceuticals Ltd
|